Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025.
Gaio V, Henriques C, Lança M, Marques R, Marques R, Rodrigues M, Almeida S, Sousa B, Freitas M, Amaral D, Ferreira S, Azevedo I, von Hafe M, Gonçalves R, Viseu R, Bandeira T, Constant C, Malato M, Carvalho I, Rodrigues J, Farinha M, Nunes T, Graça T, Gomez S, Soares S, Neves JF, Paixão P, Piscalho I, Loureiro A, Freitas C, Alves J, Soares D, Lopes P, Machado A, Guiomar R, Rodrigues AP; VigiRSV Group.
Gaio V, et al.
Influenza Other Respir Viruses. 2025 Dec;19(12):e70186. doi: 10.1111/irv.70186.
Influenza Other Respir Viruses. 2025.
PMID: 41320971
Free PMC article.